We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $45.3M
1-Year Est. Return 42.75%
This Fund
S&P 500
This Quarter Est. Return
-5.95%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$78.8M
AUM Growth
-$76.8M
Cap. Flow
-$71.7M
Cap. Flow %
-91.02%
Top 10 Hldgs %
87.97%
Holding
62
New
1
Increased
5
Reduced
24
Closed
21

Top Buys

Rank Stock Value
1
STNE icon
StoneCo
STNE
+$14.1M
2
SPGI icon
S&P Global
SPGI
+$858K
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$195K
4
AEM icon
Agnico Eagle Mines
AEM
+$178K
5
XOM icon
ExxonMobil
XOM
+$64.4K

Top Sells

Rank Stock Value
1
XP icon
XP
XP
+$29.9M
2
NGD
New Gold Inc
NGD
+$7.03M
3
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$3.99M
4
NU icon
Nu Holdings
NU
+$2.69M
5
INTR icon
Inter&Co
INTR
+$1.31M

Sector Composition

Rank Sector Weight
1 Technology 30.81%
2 Financials 22.95%
3 Healthcare 19.21%
4 Materials 1.15%
5 Energy 0.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STNE icon
1
StoneCo
STNE
$2.67B
$24.3M 30.81%
2,024,080
+958,380
+90% +$14.1M
NU icon
2
Nu Holdings
NU
$70.1B
$15.8M 20.11%
1,229,300
-230,700
-16% -$2.69M
SPGI icon
3
S&P Global
SPGI
$130B
$2.23M 2.83%
5,000
+2,000
+67% +$858K
LLY icon
4
Eli Lilly
LLY
$1.07T
$1.95M 2.47%
2,152
-25
-1% -$20K
INCY icon
5
Incyte
INCY
$23.8B
$1.91M 2.42%
31,434
-6
-0% -$340
ONC
6
BeOne Medicines Ltd
ONC
$33.7B
$1.49M 1.9%
10,464
-7
-0.1% -$1.08K
UNH icon
7
UnitedHealth
UNH
$380B
$1.22M 1.55%
2,401
-29
-1% -$14.2K
ISRG icon
8
Intuitive Surgical
ISRG
$128B
$785K 1%
1,764
-21
-1% -$8.36K
TMO icon
9
Thermo Fisher Scientific
TMO
$208B
$768K 0.97%
1,388
-16
-1% -$9.17K
ELV icon
10
Elevance Health
ELV
$82B
$634K 0.8%
1,170
-14
-1% -$7.4K
MRK icon
11
Merck
MRK
$325B
$618K 0.79%
4,995
-58
-1% -$7.47K
ACAD icon
12
Acadia Pharmaceuticals
ACAD
$4.35B
$597K 0.76%
36,740
-15
-0% -$242
SYK icon
13
Stryker
SYK
$129B
$575K 0.73%
1,689
-20
-1% -$6.78K
VRTX icon
14
Vertex Pharmaceuticals
VRTX
$123B
$490K 0.62%
1,046
-12
-1% -$5.21K
DHR icon
15
Danaher
DHR
$135B
$465K 0.59%
1,861
-22
-1% -$5.56K
AEM icon
16
Agnico Eagle Mines
AEM
$72.5B
$425K 0.54%
6,497
+2,732
+73% +$178K
ARGX icon
17
argenx
ARGX
$56.1B
$381K 0.48%
887
-9
-1% -$3.44K
MDGL icon
18
Madrigal Pharmaceuticals
MDGL
$12.8B
$373K 0.47%
1,333
– –
AZN icon
19
AstraZeneca
AZN
$265B
$361K 0.46%
2,316
-27
-1% -$4.06K
XOM icon
20
ExxonMobil
XOM
$641B
$353K 0.45%
3,066
+553
+22% +$64.4K
BMRN icon
21
BioMarin Pharmaceuticals
BMRN
$11.7B
$347K 0.44%
4,213
-12
-0.3% -$999
REGN icon
22
Regeneron Pharmaceuticals
REGN
$70.9B
$346K 0.44%
329
-4
-1% -$3.88K
AMGN icon
23
Amgen
AMGN
$204B
$327K 0.42%
1,048
-12
-1% -$3.52K
ALNY icon
24
Alnylam Pharmaceuticals
ALNY
$37.5B
$300K 0.38%
+1,233
New +$195K
AGI icon
25
Alamos Gold
AGI
$12.4B
$242K 0.31%
15,452
– –
1
2 3

Similar funds

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
NA
Novus Advisors Greenville, South Carolina $44.7M AUM 18.41% 1-Year Est. Return
CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

JGP Global Gestao de Recursos's Q2 2024 Portfolio in Review

As of Q2 2024, JGP Global Gestao de Recursos held 62 positions worth $78.8M, down 49% from $156M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

JGP Global Gestao de Recursos withdrew a net $71.7M in Q2 2024, closing 21 positions and reducing 24 holdings. Its most notable exit was XP, an estimated $29.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

Against the trend, JGP Global Gestao de Recursos opened a new position in Alnylam Pharmaceuticals worth $300K.

  • JGP Global Gestao de Recursos's largest Q2 2024 buy was Alnylam Pharmaceuticals: 1,233 shares worth $300K.
  • JGP Global Gestao de Recursos added most to StoneCo in Q2 2024, an estimated $14.1M increase.
  • JGP Global Gestao de Recursos's biggest Q2 2024 reduction was New Gold Inc, cutting an estimated $7.03M.
  • JGP Global Gestao de Recursos fully exited XP in Q2 2024, selling an estimated $29.9M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 88% of its $78.8M portfolio in Q2 2024.
  • JGP Global Gestao de Recursos opened 1 new position and closed 21 in Q2 2024.
  • JGP Global Gestao de Recursos's portfolio value fell 49% quarter-over-quarter to $78.8M.

Based on JGP Global Gestao de Recursos's 13F filing for Q2 2024, filed 2 Aug 2024.